



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1928






                                    ANSWERED ON: 
                                

12.02.2021






Oxford-Astra Zeneca Vaccine




Saptagiri Sankar Ulaka













                                                    Kumbakudi Sudhakaran
                                                












                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) whether the Government is aware that the Oxford- Astra Zeneca vaccine is being sold to European Union nations at comparatively lower price that to India;(b) if so, the reasons for the higher cost of vaccines purchased by the Indian Government;(c) whether the Government has sought explanations or reparations from the vaccine manufacturer in light of the price difference;(d) if so, the details thereof and if not, the reasons therefor;(e) whether the Government is negotiating a lower price for purchasing the same vaccine in the future; and(f) if so, the details thereof and if not, the reasons therefor?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a): As per available information, the price of Oxford-Astra Zeneca vaccine across the world is in the range of about US$ 4 to US$ 5.25. For COVAX AMC Facility that pools the demand and supplies for 191 participating countries, including European Union nations, the price is US$ 3 per dose to US$ 3.15 per dose, which is largely on account of advance payment done to the Vaccine Manufacturer, much before their vaccine completed clinical trial and obtained licensure from the Regulator. The Covishield vaccine (Oxford-Astra Zeneca vaccine) by M/s Serum Institute of India is being procured by Govt. of India at a lower price of INR 210 which is around US$ 2.7 per dose.(b) to (f): In view of (a) above, question does not arise.
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113203861







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







